针对两个二分类共同主要终点的精确随机两阶段2期临床试验设计
针对两个二分类共同主要终点的两臂两阶段2期试验,该研究基于双变量二项分布开发精确设计和模拟设计方法,允许两臂间终点相关性不同,并在第一阶段因无效提前终止。小样本(每臂约n≤25)时精确法计算可行且给出解析精确操作特性;样本量较大时精确计算密集,模拟法选出的设计与精确法接近,而正态近似常偏离,作者推荐模拟法作为中至大样本试验的高效准确替代。
要点
- 精确法在每臂约n≤25时计算可行,给出解析精确操作特性。
- 模拟法选出的设计与精确法接近,正态近似常偏离。
- 作者推荐模拟法用于中至大样本量试验设计。
核心结论
- 作者推荐模拟法作为中至大样本量试验中计算高效且准确的替代方法。
- 模拟法选出的设计与精确法接近,而正态近似常偏离。
研究设计与样本
- 研究开发了基于双变量二项分布的两臂两阶段2期试验精确与模拟设计方法,用于两个二分类共同主要终点,允许两臂间终点相关性不同。
- 框架可识别最小化期望样本量的最优设计和最小化最大样本量的极小极大设计,并允许第一阶段因无效提前终止。
- 对每臂约n≤25的小样本,精确法计算可行,在假定双变量二项分布下给出解析精确操作特性;样本量较大时精确计算密集。
主要发现
- 小样本(每臂约n≤25)时精确法计算可行且给出解析精确操作特性。
- 模拟法选出的设计与精确法接近,正态近似常偏离。
关键数值与推荐
- 每臂约n≤25时精确法计算可行。
- 模拟法选出的设计与精确法接近,正态近似常偏离。
临床怎么用
- 作者推荐模拟法作为中至大样本量试验中计算高效且准确的替代方法。
局限性
- 样本量较大时精确计算变得密集。
- 正态近似常偏离精确法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Phase 2 clinical trials typically rely on a single primary endpoint, yet in many settings, treatment efficacy must be demonstrated across multiple co-primary endpoints. Such settings require intersection-union hypothesis testing, in which the global null hypothesis is rejected only when all individual component hypotheses are rejected. Existing phase 2 designs for binary endpoints are largely restricted to single-arm or single-endpoint settings, or rely on large-sample normal approximations for two-arm trials, which may be inadequate when sample sizes are small. We developed exact and simulation-based methods for designing two-arm, two-stage phase 2 trials with two co-primary binary endpoints using the bivariate binomial distribution, allowing different correlations between endpoints across treatment arms. The proposed framework identifies optimal designs that minimize the expected sample size and minimax designs that minimize the maximum sample size, while allowing early termination for futility at the first stage. For small sample sizes (approximately n ≤ 25 $$ n\le 25 $$ per arm), the exact method is computationally feasible and yields analytically exact operating characteristics under the assumed bivariate binomial distribution. For larger sample sizes, however, exact computations become intensive. To address this, we evaluated a simulation-based approach and a normal approximation by comparing their performance against the exact method. The simulation approach selected designs that closely matched those from the exact method, whereas the normal approximation often deviated. Therefore, we recommend the simulation-based method as a computationally efficient and accurate alternative for moderate-to-large sample size trials.
引用
- Jung H, Mitani AA, Ishrat Husain M, et al. Exact Randomized Two-Stage Phase 2 Clinical Trial Designs for Two Binary Co-Primary Endpoints. Stat Med. 2026. PMID: 41664995. doi:10.1002/sim.70424
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。